Hamlet BioPharma Balance Sheet Health
Financial Health criteria checks 6/6
Hamlet BioPharma has a total shareholder equity of SEK45.8M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK54.3M and SEK8.4M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
| Interest coverage ratio | n/a |
| Cash | kr6.23m |
| Equity | kr45.84m |
| Total liabilities | kr8.43m |
| Total assets | kr54.27m |
Recent financial health updates
Is Hamlet Pharma (NGM:HAMLET B) In A Good Position To Invest In Growth?
Jul 04
Here's Why We're Watching Hamlet Pharma's (NGM:HAMLET B) Cash Burn Situation
Mar 04We Think Hamlet Pharma (NGM:HAMLET B) Can Afford To Drive Business Growth
Nov 10We Think Hamlet Pharma (NGM:HAMLET B) Can Easily Afford To Drive Business Growth
Jun 17Companies Like Hamlet Pharma (NGM:HAMLET B) Are In A Position To Invest In Growth
Oct 12Will Hamlet Pharma (NGM:HAMLET B) Spend Its Cash Wisely?
Mar 17Recent updates
Is Hamlet Pharma (NGM:HAMLET B) In A Good Position To Invest In Growth?
Jul 04Here's Why We're Watching Hamlet Pharma's (NGM:HAMLET B) Cash Burn Situation
Mar 04We Think Hamlet Pharma (NGM:HAMLET B) Can Afford To Drive Business Growth
Nov 10We Think Hamlet Pharma (NGM:HAMLET B) Can Easily Afford To Drive Business Growth
Jun 17Companies Like Hamlet Pharma (NGM:HAMLET B) Are In A Position To Invest In Growth
Oct 12Will Hamlet Pharma (NGM:HAMLET B) Spend Its Cash Wisely?
Mar 17Financial Position Analysis
Short Term Liabilities: HAMLET B's short term assets (SEK7.9M) exceed its short term liabilities (SEK3.4M).
Long Term Liabilities: HAMLET B's short term assets (SEK7.9M) exceed its long term liabilities (SEK5.0M).
Debt to Equity History and Analysis
Debt Level: HAMLET B is debt free.
Reducing Debt: HAMLET B had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: HAMLET B has sufficient cash runway for 2 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: HAMLET B is forecast to have sufficient cash runway for 3 months based on free cash flow estimates, but has since raised additional capital.